FDA Import Refusal AEK-9687889-5/10002/1 — Glaxosmithkline

Glaxosmithkline — FEI 3003451948

The FDA refused shipment AEK-9687889-5/10002/1 from Glaxosmithkline (United Kingdom) on Oct 8, 2026. The refused product falls under Drugs and Biologics — AZELASTINE HYDROCHLORIDE/FLUTICASONE, ANTI-HISTAMINE STEROID (ANTI-HISTAMINIC). Cited charge: 75 This firm has 5 or more other import refusals on record.

Refusal Details

Date
Oct 8, 2026
Country
United Kingdom
Product Category
Drugs and Biologics
Product Code
61XAR50 AZELASTINE HYDROCHLORIDE/FLUTICASONE, ANTI-HISTAMINE STEROID (ANTI-HISTAMINIC)
Charges
75

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.